Your browser doesn't support javascript.
loading
HLA tapasin independence: broader peptide repertoire and HIV control.
Bashirova, Arman A; Viard, Mathias; Naranbhai, Vivek; Grifoni, Alba; Garcia-Beltran, Wilfredo; Akdag, Marjan; Yuki, Yuko; Gao, Xiaojiang; O'hUigin, Colm; Raghavan, Malini; Wolinsky, Steven; Bream, Jay H; Duggal, Priya; Martinson, Jeremy; Michael, Nelson L; Kirk, Gregory D; Buchbinder, Susan P; Haas, David; Goedert, James J; Deeks, Steven G; Fellay, Jacques; Walker, Bruce; Goulder, Philip; Cresswell, Peter; Elliott, Tim; Sette, Alessandro; Carlson, Jonathan; Carrington, Mary.
  • Bashirova AA; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • Viard M; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • Naranbhai V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.
  • Grifoni A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.
  • Garcia-Beltran W; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139.
  • Akdag M; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • Yuki Y; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • Gao X; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • O'hUigin C; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • Raghavan M; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109.
  • Wolinsky S; Division of Infectious Diseases, The Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.
  • Bream JH; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
  • Duggal P; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
  • Martinson J; Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15261.
  • Michael NL; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
  • Kirk GD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
  • Buchbinder SP; HIV Research Section, San Francisco Department of Public Health, San Francisco, CA 94102.
  • Haas D; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37204.
  • Goedert JJ; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850.
  • Deeks SG; Department of Medicine, University of California, San Francisco, CA 94110.
  • Fellay J; School of Life Sciences, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.
  • Walker B; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Goulder P; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139.
  • Cresswell P; Department of Paediatrics, University of Oxford, Oxford, OX1 4AJ, United Kingdom.
  • Elliott T; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
  • Sette A; Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, United Kingdom.
  • Carlson J; Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, United Kingdom.
  • Carrington M; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037.
Proc Natl Acad Sci U S A ; 117(45): 28232-28238, 2020 11 10.
Article en En | MEDLINE | ID: mdl-33097667
ABSTRACT
Human leukocyte antigen (HLA) class I allotypes vary in their ability to present peptides in the absence of tapasin, an essential component of the peptide loading complex. We quantified tapasin dependence of all allotypes that are common in European and African Americans (n = 97), which revealed a broad continuum of values. Ex vivo examination of cytotoxic T cell responses to the entire HIV-1 proteome from infected subjects indicates that tapasin-dependent allotypes present a more limited set of distinct peptides than do tapasin-independent allotypes, data supported by computational predictions. This suggests that variation in tapasin dependence may impact the strength of the immune responses by altering peptide repertoire size. In support of this model, we observed that individuals carrying HLA class I genotypes characterized by greater tapasin independence progress more slowly to AIDS and maintain lower viral loads, presumably due to increased breadth of peptide presentation. Thus, tapasin dependence level, like HLA zygosity, may serve as a means to restrict or expand breadth of the HLA-I peptide repertoire across humans, ultimately influencing immune responses to pathogens and vaccines.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Transporte de Membrana / Antígenos de Histocompatibilidad Clase I / Infecciones por VIH / Presentación de Antígeno Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Transporte de Membrana / Antígenos de Histocompatibilidad Clase I / Infecciones por VIH / Presentación de Antígeno Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article